A Study to Learn About a Vaccine Against E Coli in Healthy Adults

Study Summary

This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.

Conditions

Healthy Participants

Interventions / Drugs

E coli vaccine 1 Dose A E coli vaccine 1 Dose B E coli vaccine 2 E coli vaccine 3 E coli Vaccine 4 Dose A E coli Vaccine 4 Dose B E coli Vaccine 4 Dose C E coli Vaccine 5 Dose A E coli Vaccine 5 Dose B Placebo

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment310 participants

Primary Completion—

Lead SponsorPfizer

Data Retrieved2026-04-11 02:55:53.190561+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.